A 42-year-old female with stage 3 chronic kidney disease due to polycystic kidney disease is experiencing hyperkalemia with a serum potassium level of 5.8 mEq/L. Which of the following interventions should the nurse prioritize to address this electrolyte imbalance?

C) Administer sodium polystyrene sulfonate (Kayexalate) to promote potassium excretion.

A) Administer a calcium channel blocker to reduce blood pressure.

B) Prepare the patient for hemodialysis to rapidly decrease potassium levels.

C) Administer sodium polystyrene sulfonate (Kayexalate) to promote potassium excretion.

D) Increase the patient's fluid intake to dilute serum potassium levels.

A 42-year-old female patient with Polycystic Kidney Disease (PKD) is experiencing stage 3 chronic kidney disease (CKD) with an eGFR of 40 mL/min/1.73m², elevated serum creatinine and BUN levels, and hyperkalemia with a potassium level of 5.8 mEq/L. Which nursing intervention should be prioritized to address her current condition?

B) Administer sodium polystyrene sulfonate (Kayexalate) as prescribed to lower potassium levels.

A) Encourage the patient to increase fluid intake to enhance kidney function.

B) Administer sodium polystyrene sulfonate (Kayexalate) as prescribed to lower potassium levels.

C) Educate the patient on the importance of a high-protein diet to support kidney health.

D) Increase the dose of Lisinopril to better control her blood pressure.

A patient with polycystic kidney disease (PKD) and chronic kidney disease (CKD) presents with persistent hyperkalemia despite initial management efforts. An ECG reveals peaked T waves and premature ventricular contractions (PVCs). After administering calcium gluconate, insulin with glucose, and considering sodium polystyrene sulfonate, which additional intervention should the nurse anticipate to further manage this patient's condition?

A) Increase dietary potassium intake

D) Discontinue all antihypertensive medications

A patient with polycystic kidney disease (PKD) and concurrent chronic kidney disease (CKD) presents with hyperkalemia and cardiac symptoms. After initial treatment with calcium gluconate, insulin with glucose, and consideration of sodium polystyrene sulfonate, the healthcare team decides to add a diuretic to the patient's antihypertensive regimen. What is the primary nursing consideration when administering the diuretic in this scenario?

A) Monitoring for signs of dehydration and electrolyte imbalance.

B) Ensuring the patient maintains a high potassium diet to offset losses.

C) Educating the patient about the potential for increased drowsiness.

D) Advising the patient to limit fluid intake to prevent fluid overload.

A patient with a history of polycystic kidney disease (PKD) and chronic kidney disease (CKD) is experiencing elevated creatinine and BUN levels following diuretic therapy. The healthcare team suspects prerenal azotemia due to volume depletion. What is the most appropriate initial nursing intervention to address this patient's current condition?

B) Initiate isotonic fluid replacement and monitor urine output closely.

A) Administer hypotonic saline to rapidly correct fluid balance.

B) Initiate isotonic fluid replacement and monitor urine output closely.

C) Increase the diuretic dose to enhance renal excretion of waste products.

D) Restrict fluid intake to prevent potential fluid overload.

A patient with chronic kidney disease (CKD) and polycystic kidney disease (PKD) is experiencing increasing creatinine levels and decreased urine output following diuretic therapy. The healthcare team suspects prerenal azotemia due to diuretic-induced volume depletion. What is the most appropriate nursing action to address this issue?

B) Administer isotonic fluids to improve renal perfusion.

A) Increase the diuretic dosage to promote diuresis.

B) Administer isotonic fluids to improve renal perfusion.

C) Restrict fluid intake to prevent fluid overload.

D) Encourage the patient to increase oral fluid intake.

A patient with a history of hypertension and renal impairment is being treated with cautious fluid replacement and a reduced diuretic dose. Despite improved urine output and stable blood pressure, the patient develops mild peripheral edema and gains 1.5 kg in weight. What is the most appropriate nursing intervention to address the patient’s current condition?

B) Initiate a low-sodium diet to help manage fluid retention.

A) Increase the diuretic dose to reduce fluid overload.

B) Initiate a low-sodium diet to help manage fluid retention.

C) Reduce the fluid intake to prevent further fluid accumulation.

D) Monitor the patient’s blood pressure and weight daily without changing the current plan.

A patient with a history of hypertension and renal impairment is being monitored for fluid balance after changes in her treatment regimen. She is experiencing mild peripheral edema and a 1.5 kg weight gain since the initiation of isotonic fluid therapy. Which nursing intervention is most appropriate to address the patient's current condition?

B) Implement a low-sodium diet and reassess the diuretic regimen.

A) Increase the dose of isotonic fluids to promote renal perfusion.

B) Implement a low-sodium diet and reassess the diuretic regimen.

C) Restrict fluid intake to prevent further weight gain and edema.

D) Administer an antihypertensive medication to manage blood pressure.

A patient with moderate edema, fatigue, and shortness of breath has a sodium level of 130 mmol/L and potassium level of 5.5 mmol/L. An ECG shows peaked T waves. What is the priority nursing intervention?

A) Administer a low-dose loop diuretic with potassium-wasting properties.

B) Increase the rate of isotonic fluid administration to correct hyponatremia.

C) Provide supplemental oxygen to improve respiratory status.

D) Prepare the patient for dialysis to rapidly correct electrolyte imbalances.

A patient presents with moderate peripheral edema, dyspnea, and an electrolyte imbalance with a sodium level of 130 mmol/L and potassium level of 5.5 mmol/L. An ECG shows peaked T waves. Which nursing intervention should be prioritized to address the patient's current condition?

A) Administer a potassium-reducing medication such as sodium polystyrene sulfonate.

B) Increase the rate of isotonic fluid administration to dilute the electrolyte imbalance.

C) Encourage the patient to consume more sodium in her diet to stabilize sodium levels.

D) Initiate oxygen therapy and prepare the patient for possible dialysis.

Polycystic Kidney Disease - Nursing Case Study

Pathophysiology

• Primary mechanism: Polycystic Kidney Disease (PKD) is primarily caused by genetic mutations, most commonly in the PKD1 or PKD2 genes, leading to the formation of numerous fluid-filled cysts in the kidneys. This disrupts normal renal architecture and function.

• Secondary mechanism: The growth of these cysts leads to compression of surrounding kidney tissue, resulting in compromised blood flow, increased renin-angiotensin-aldosterone system (RAAS) activity, and subsequent hypertension.

• Key complication: The progressive enlargement of cysts can lead to chronic kidney disease (CKD) due to nephron loss, fibrosis, and eventual renal failure, necessitating dialysis or transplantation as the disease advances.

Patient Profile

Demographics:

42-year-old female, accountant

History:

• Key past medical history: Diagnosed with Polycystic Kidney Disease (PKD) 10 years ago; hypertension for 5 years

• Current medications: Lisinopril 20 mg daily, Metformin 500 mg twice daily, Atorvastatin 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in the legs

• Key symptoms: Flank pain, headache, nausea, decreased urine output

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 97% on room air

Section 1

As the healthcare team continues to monitor the 42-year-old female patient with Polycystic Kidney Disease (PKD), new diagnostic results reveal further insight into her condition. A recent laboratory workup shows a significant decline in renal function, with her estimated glomerular filtration rate (eGFR) dropping to 40 mL/min/1.73m², indicating stage 3 chronic kidney disease (CKD). Additionally, her serum creatinine level has risen to 2.2 mg/dL, and blood urea nitrogen (BUN) levels are elevated at 35 mg/dL, further confirming the deterioration of kidney function. Electrolyte imbalances are also noted, with hyperkalemia present as her potassium level is measured at 5.8 mEq/L. This poses a risk for cardiac complications, necessitating immediate attention.

Imaging studies, including a renal ultrasound, show significant enlargement of both kidneys with numerous cysts, some of which have increased in size since the last evaluation. These findings are consistent with the progression of PKD, contributing to her symptoms of flank pain and decreased urine output. The patient's blood pressure remains elevated at 150/95 mmHg, despite current antihypertensive therapy, suggesting that her hypertension may be more challenging to control as CKD progresses. This situation calls for a reassessment of her medication regimen, potentially increasing her Lisinopril dosage or adding another antihypertensive agent to better manage her blood pressure and slow the progression of kidney damage.

The healthcare team must now prioritize interventions aimed at addressing her electrolyte imbalance and optimizing her blood pressure control. Further evaluation of her cardiovascular status is essential, given the elevated potassium levels and the persistent hypertension. The team should also consider the potential need for dietary modifications and patient education to manage her CKD symptoms and prevent further complications. With these developments, the patient's treatment plan will need to be adjusted to mitigate the risks associated with her advancing kidney disease and to improve her overall quality of life.

Section 2

As the healthcare team implements interventions to address the patient's hyperkalemia and blood pressure, they notice a change in her status during a routine follow-up. The patient reports experiencing palpitations and mild shortness of breath, prompting immediate attention. A physical examination reveals a regular heart rate of 96 beats per minute, but with occasional irregularities noted during auscultation. Respiratory rate is slightly elevated at 22 breaths per minute, and oxygen saturation is at 94% on room air. Given these symptoms, an electrocardiogram (ECG) is performed, showing peaked T waves and occasional premature ventricular contractions (PVCs), consistent with hyperkalemia-induced cardiac effects.

In response to these findings, the healthcare team re-evaluates her current treatment plan. The patient's potassium level is rechecked, confirming persistent hyperkalemia at 5.9 mEq/L despite initial dietary modifications and medication adjustments. This necessitates more aggressive management, including the administration of calcium gluconate to stabilize the cardiac membrane, and insulin with glucose to drive potassium back into the cells temporarily. Additionally, sodium polystyrene sulfonate is considered to facilitate potassium excretion through the gastrointestinal tract. The team also revisits her antihypertensive regimen, introducing a diuretic to aid in both blood pressure control and potassium regulation.

As these interventions are undertaken, the patient's clinical status is closely monitored. Her blood pressure shows modest improvement, now at 140/90 mmHg, and her palpitations diminish following treatment, indicating a positive initial response. However, the team remains vigilant for any new complications, recognizing the need for ongoing assessment and potential further adjustments to her treatment plan. This situation underscores the complexity of managing PKD with concurrent CKD, highlighting the importance of a multifaceted approach to prevent further deterioration and enhance the patient's quality of life.

Section 3

As the patient's treatment progresses, the healthcare team observes a change in her renal function that warrants further investigation. Despite the initial positive response to hyperkalemia management, her creatinine levels begin to rise, now recorded at 2.8 mg/dL, up from a previous baseline of 2.3 mg/dL. This elevation in creatinine suggests a worsening of her chronic kidney disease (CKD), which may be exacerbated by the introduction of the diuretic. Additionally, her blood urea nitrogen (BUN) has increased to 45 mg/dL, further indicating a decline in renal function.

These new diagnostic results prompt the team to re-evaluate her fluid status and medication regimen. The possibility of prerenal azotemia due to diuretic-induced volume depletion is considered, necessitating careful assessment of her hydration status. The patient's skin turgor appears slightly decreased, and she reports a modest reduction in urine output, which supports this hypothesis. As a result, the team decides to cautiously adjust her diuretic dose and initiate isotonic fluid replacement to optimize renal perfusion while continuing to monitor her electrolytes closely.

The team is mindful of the delicate balance required in managing her PKD and CKD, recognizing that aggressive fluid management could potentially exacerbate her hypertension or lead to edema. This situation highlights the importance of individualized care and vigilant monitoring, as they strive to stabilize her renal function without compromising other aspects of her health. Moving forward, the priority shifts to ensuring her renal function stabilizes, while preventing further complications, such as fluid overload or progression of hypertension, paving the way for further adjustments in her therapeutic plan.

Section 4

Following the adjustments to the patient's treatment plan, the healthcare team closely monitors her response to the interventions. Over the next 48 hours, they observe a slight improvement in her urine output, which has increased from 400 mL to 650 mL per 24 hours. Her blood pressure remains stable, averaging 138/86 mmHg, indicating that the cautious fluid replacement strategy is not adversely affecting her hypertension. However, new laboratory results indicate that her creatinine level, while slightly improved at 2.6 mg/dL, is still elevated. Her BUN has decreased to 40 mg/dL, suggesting a modest improvement in her renal perfusion and a positive initial response to the reduced diuretic dose and isotonic fluid administration.

Despite these encouraging signs, the patient begins to experience mild peripheral edema in her lower extremities, a new complication that could signal a developing fluid overload. This finding prompts the team to reassess her fluid management strategy. While the isotonic fluids have improved renal perfusion, the onset of edema suggests that her fluid balance remains a delicate issue. The team must now consider whether the current fluid regimen should be further modified to prevent exacerbation of her condition.

As the team deliberates the next steps, they are mindful of the need for a balanced approach. The patient's weight is monitored daily, showing a 1.5 kg increase since the initiation of fluid therapy. This weight gain, coupled with her edema, underscores the need for a nuanced adjustment of her fluid and electrolyte management. The team plans to introduce a low-sodium diet and consider a different diuretic strategy to address the edema while maintaining stable renal function. Through careful monitoring and continued assessment, the goal is to optimize her overall condition, preventing further renal decline and avoiding additional complications.

Section 5

New Complications:

Over the next 24 hours, the healthcare team notices that the patient's mild peripheral edema has progressed to moderate edema, extending to her hands and face. Additionally, she reports feeling increasingly fatigued and short of breath, particularly when lying flat. These symptoms suggest the possibility of fluid overload extending beyond the peripheral tissues, potentially affecting her respiratory system. Her vital signs show a slight increase in respiratory rate to 22 breaths per minute, with oxygen saturation dipping to 92% on room air. This change raises concerns about potential pulmonary involvement, warranting further investigation.

New laboratory results reveal an unexpected electrolyte imbalance. Her sodium level has decreased to 130 mmol/L, which might be contributing to her symptoms of fatigue and confusion, while her potassium level has risen to 5.5 mmol/L, raising concerns for cardiac stability. An urgent electrocardiogram is conducted, revealing peaked T waves, consistent with hyperkalemia. This new development necessitates immediate intervention to correct the electrolyte imbalance and mitigate the risk of cardiac complications.

The team promptly evaluates the fluid management strategy, recognizing the need to address both the edema and the electrolyte disturbances. They decide to reduce the rate of isotonic fluid administration and initiate a low-dose loop diuretic with potassium-wasting properties, while closely monitoring her electrolyte levels and renal function. Additionally, supplemental oxygen is provided to alleviate her respiratory symptoms, and further dietary modifications are discussed to manage her sodium intake effectively. Through these targeted interventions, the team aims to stabilize her condition, carefully balancing fluid and electrolyte management to prevent further complications and support her recovery.